Special mention is required for cases that would fit within LYSA group 0 of Sarkozy et al. [1], which includes cases histologically resembling typical CHL that express uniform and strong CD20 and other B cell markers (such as OCT2, BOB1, PAX5, and/or CD79a). This evidence concerns the gene CD79A and classic Hodgkin lymphoma.